Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Janice M Reichert, Alain Beck, Alexey A Lugovskoy, Thierry Wurch, Steven Coats & Randall J Brezski. (2014) 9th Annual European Antibody Congress, November 11–13, 2013, Geneva, Switzerland. mAbs 6:2, pages 309-326.
Read now
Read now
Articles from other publishers (5)
A. Ljungars, L. Mårtensson, J. Mattsson, M. Kovacek, A. Sundberg, U-C. Tornberg, B. Jansson, N. Persson, V. Kuci Emruli, S. Ek, M. Jerkeman, M. Hansson, G. Juliusson, M. Ohlin, B. Frendéus, I. Teige & M. Mattsson. (2018) A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia. npj Precision Oncology 2:1.
Crossref
Crossref
Wei Li, Iok-Hou Pang, Mario Thiego F. Pacheco & Hong Tian. (2018) Ligandomics: a paradigm shift in biological drug discovery. Drug Discovery Today 23:3, pages 636-643.
Crossref
Crossref
Ralph R. Minter, Alan M. Sandercock & Steven J. Rust. (2017) Phenotypic screening—the fast track to novel antibody discovery. Drug Discovery Today: Technologies 23, pages 83-90.
Crossref
Crossref
Andrea L. Gonzalez-Munoz, Ralph R. Minter & Steven J. Rust. (2016) Phenotypic screening: the future of antibody discovery. Drug Discovery Today 21:1, pages 150-156.
Crossref
Crossref
Dermot O’Sullivan, Michael Henry, Helena Joyce, Naomi Walsh, Edel Mc Auley, Paul Dowling, Niall Swan, Michael Moriarty, Paul Barnham, Martin Clynes & Annemarie Larkin. (2014) 7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells. Tumor Biology 35:7, pages 6983-6997.
Crossref
Crossref